Buyne Otmar R, Bleichrodt Robert P, Verweij Paul E, Groenewoud Hans M M, van Goor Harry, Hendriks Thijs
Department of Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
Int J Exp Pathol. 2006 Oct;87(5):361-8. doi: 10.1111/j.1365-2613.2006.00488.x.
Intra-abdominal abscesses are a potential source of recurrent or residual infection after surgical intervention for secondary peritonitis. The development of therapies requires a model which combines low mortality with the formation of persisting abscesses and which is also suitable to study the local inflammatory response. Male Wistar rats were injected intraperitoneally with a mixture of sterile rat faeces, increasing doses of E. coli (10(4)-10(8) cfu/ml) and a fixed dose of B. Fragilis (10(4) cfu/ml). After one h a laparotomy was performed and the peritoneal cavity was debrided. Blood samples were taken under anaesthesia after 6 and 24 h. Abdominal fluid samples were collected (by laparotomy) after 24 and 72 h. The rats were killed after 5 days and the abdomen was inspected for abscesses. Mortality was 90% in the two groups with the highest doses of E. coli and 30% in those with the two lowest doses. In the latter groups all surviving rats but one showed intraabdominal abscesses and bacteremia was encountered frequently, especially after 24 h in the 10(5) cfu E. coli group. The groups receiving 10(4)-10(6) cfu E. coli showed similar plasma IL-6 concentrations after 6 h which were lowered significantly after 24 h. No circulating TNF-alpha was found. Considerable concentrations of TNF-alpha, IL-6, IL-1beta, and IL-10, were found in the peritoneal fluid after 24 h but no differences were observed between the contro groups and those receiving 10(4)-10(6) cfu E. coli. At 72 h cytokine levels were reduced significantly and remained the highest in the animals dosed with 10(6) cfu E. coli. The present model is suitable to study the mechanisms involved in, and prevention of, intra-abdominal abscess formation after surgical treatment of generalized peritonitis.
腹腔内脓肿是继发性腹膜炎手术干预后复发或残留感染的潜在来源。治疗方法的开发需要一种模型,该模型具有低死亡率且能形成持续存在的脓肿,并且还适合研究局部炎症反应。将雄性Wistar大鼠腹腔内注射无菌大鼠粪便、递增剂量的大肠杆菌(10⁴ - 10⁸ cfu/ml)和固定剂量的脆弱拟杆菌(10⁴ cfu/ml)的混合物。1小时后进行剖腹手术并清理腹腔。在6小时和24小时麻醉状态下采集血样。在24小时和72小时后(通过剖腹手术)收集腹腔液样本。5天后处死大鼠并检查腹部有无脓肿。大肠杆菌剂量最高的两组死亡率为90%,剂量最低的两组死亡率为30%。在后者的组中,除一只外所有存活大鼠均出现腹腔内脓肿,并且经常出现菌血症,尤其是在10⁵ cfu大肠杆菌组的24小时后。接受10⁴ - 10⁶ cfu大肠杆菌的组在6小时后血浆IL - 6浓度相似,在24小时后显著降低。未发现循环中的TNF - α。24小时后在腹腔液中发现了相当浓度的TNF - α、IL - 6、IL - 1β和IL - 10,但对照组与接受10⁴ - 10⁶ cfu大肠杆菌的组之间未观察到差异。在72小时时细胞因子水平显著降低,并且在给予10⁶ cfu大肠杆菌的动物中仍最高。本模型适合研究全身性腹膜炎手术治疗后腹腔内脓肿形成所涉及的机制及预防。